GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » The Joint Corp (NAS:JYNT) » Definitions » 10-Year RORE %

The Joint (The Joint) 10-Year RORE % : 10.47% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is The Joint 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. The Joint's 10-Year RORE % for the quarter that ended in Mar. 2024 was 10.47%.

The industry rank for The Joint's 10-Year RORE % or its related term are showing as below:

JYNT's 10-Year RORE % is ranked better than
56.01% of 291 companies
in the Healthcare Providers & Services industry
Industry Median: 8.11 vs JYNT: 10.47

The Joint 10-Year RORE % Historical Data

The historical data trend for The Joint's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Joint 10-Year RORE % Chart

The Joint Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -2.35 15.00

The Joint Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.06 -27.55 -18.53 15.00 10.47

Competitive Comparison of The Joint's 10-Year RORE %

For the Medical Care Facilities subindustry, The Joint's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Joint's 10-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, The Joint's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where The Joint's 10-Year RORE % falls into.



The Joint 10-Year RORE % Calculation

The Joint's 10-Year RORE % for the quarter that ended in Mar. 2024 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( -0.76--0.587 )/( -1.653-0 )
=-0.173/-1.653
=10.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2024 and 10-year before.


The Joint  (NAS:JYNT) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


The Joint 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of The Joint's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


The Joint (The Joint) Business Description

Traded in Other Exchanges
N/A
Address
16767 North Perimeter Drive, Suite 110, Scottsdale, AZ, USA, 85260
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sale of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.
Executives
Bandera Partners Llc 10 percent owner 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Peter D Holt officer: Chief Operating Officer 16767 N. PERIMETER DR., SUITE 240, SCOTTSDALE AZ 85260
Jake Singleton officer: Chief Financial Officer 16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Ronald V Davella director 2600 E SOUTHLAKE BLVD., STE 120-359, SOUTHLAKE TX 76092
Glenn J Krevlin 10 percent owner 600 FIFTH AVE, 11TH FL, NEW YORK NY 10020
Matthew E Rubel director 3231 SE SIXTH AVENUE, TOPEKA KS 66607
Gregory Bylinsky 10 percent owner C/O BANDERA PARTNERS LLC, 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Jefferson Gramm 10 percent owner C/O BANDERA PARTNERS LLC, 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Amos James H. Jr director 16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
John P Meloun officer: Chief Financial Officer 16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
Abe Hong director 16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Glenhill Advisors Llc 10 percent owner 600 FIFTH AVE, 11TH FL, NEW YORK NY 10020
Suzanne M Decker director 16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Bret Sanders director 16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
David M Orwasher officer: President and COO 242 W 36TH ST, NEW YORK NY 10018